Results 21 to 30 of about 1,073 (146)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement [PDF]

Orphanet Journal of Rare Diseases, 2017
Background Graves’ orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status.
P. Perros, L. Hegedüs, L. Bartalena, C. Marcocci, G. J. Kahaly, L. Baldeschi, M. Salvi, J. H. Lazarus, A. Eckstein, S. Pitz, K. Boboridis, P. Anagnostis, G. Ayvaz, A. Boschi, T. H. Brix, N. Currò, O. Konuk, M. Marinò, A. L. Mitchell, B. Stankovic, F. B. Törüner, G. von Arx, M. Zarković, W. M. Wiersinga   +23 more
doaj   +4 more sources

Evaluation of the Graves’ Orbitopathy-Specific Quality of Life Questionnaire in the Mainland Chinese Population

Journal of Ophthalmology, 2019
Purpose. To study the clinical significance of the Graves’ orbitopathy-specific quality of life (GO-QOL) questionnaire in mainland Chinese patients. Methods.
Peng Zeng, Shu-xian Fan, Zi-jing Li, Yuan-yu Peng, Yu-xin Hu, Ming-tong Xu, Mei Wang   +6 more
doaj   +2 more sources

Quality of life in Graves' orbitopathy [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2011
The quality of life of patients with Graves' orbitopathy (GO) may be seriously damaged due to the changes in appearance, working abilities and everyday activities. The reasons for the deterioration in quality of life in GO are proptosis, diplopiae and/or
Ćirić Jasmina
doaj   +2 more sources

Multidisciplinary management of thyroid eye disease (TED) in patients with latent tuberculosis or chronic hepatitis B [PDF]

Thyroid Research
Background Intravenous methylprednisolone (IVMP) is a first-line treatment for active moderate-severe or sight-threatening thyroid eye disease (TED), but the presence of systemic infections such as latent tuberculosis (TB) or chronic hepatitis B virus ...
John S. Vekinis, Jonathan Lee, Vickie Lee, Ahmad Aziz, Rajni Jain, Claire Feeney, Vassiliki Bravis   +6 more
doaj   +2 more sources

Thyroid Eye Disease Following SARS-CoV-2 Vaccination: Experience of a Case Series [PDF]

Vaccines
Background: Thyroid eye disease (TED), or Graves’ orbitopathy, is the most common extra-thyroidal manifestation of Graves’ disease, but it has only rarely been reported after SARS-CoV-2 vaccination.
Alin Abreu Lomba, María Elena Tello-Cajiao, Mónica Morales, Alexander Martínez, Mauricio Andrés Salazar Moreno, David Alexander Vernaza Trujillo, Alice Gaibor-Pazmiño, Juan S. Izquierdo-Condoy   +7 more
doaj   +2 more sources

International Symposium for Thyroid Eye Disease (June 2016, London) [PDF]

Клиническая и экспериментальная тиреоидология, 2017
In June 2016, an International Symposium dedicated to the cutting edge research and achievements in Thyroid Eye Disease (TED) diagnosis and treatment was held in London. The symposium was organized by the International Thyroid Eye Disease (ITEDs). It was
Natalia Y. Sviridenko, Marina S. Sheremeta, Yaroslav O. Grusha   +2 more
doaj   +2 more sources

Presentation of Graves’ orbitopathy within European Group On Graves’ Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III) [PDF]

, 2023
Background Graves orbitopathy (GO) is subject to epidemiological and care-related changes. Aim of the survey was to identify trends in presentation of GO to the European Group On Graves’ Orbitopathy (EUGOGO) tertiary referral centres and initial ...
Perez-Lopez M., Mandic J. J., Beleslin B. N., Quinn A., Covelli D., Eckstein A. K., Bechtold D., Brix T. H., Fuhrer D., Toruner F., Jablonska-Pawlak A., Kahaly G. J., Langbein A., Ayvaz G., Rudofsky G., Tanda M. L., Hintschich C. R., Miskiewicz P., Schuh A., Boschi A., Ciric J., Salvi M., Vaidya B., Curro N., Baldeschi L., Burlacu M. -C., Schittkowski M. P., Marino M., Ponto K. A., Perez-Lazaro A., Lanzolla G., Baretic M., Horn M., Konuk O., Donati S., Marcocci C., Fichter N.   +36 more
core   +4 more sources

Lamina cribrosa curvature depth and index as novel parameters in Graves’ ophthalmopathy [PDF]

Scientific Reports
This study aims to evaluate lamina cribrosa (LC) parameters, macular ganglion cell layer thickness (GCLT) and peripapillary retina nerve fiber layer thickness (RNFLT) in Graves’ Ophthalmopathy (GO) patients using spectral domain optical coherence ...
Abdullah Ergen, Büşra Yılmaz Tuğan
doaj   +2 more sources

Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO). [PDF]

, 2022
Graves’ disease (GB), also known as Basedow’s disease, is the most common cause of hyperthyroidism, and thyroid orbitopathy (TO) is its most common non-thyroid manifestation with an incidence of 42.2/million people/year.
Kajdaniuk, Dariusz; Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, Marek, Bogdan; Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, Londzin-Olesik, Magdalena; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Siemińska, Lucyna; Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, Głogowska-Szeląg, Joanna; Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, Nowak, Wojciech; Science Students’ Association, Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland, Kos-Kudła, Beata; Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Nowak, Mariusz; Pathophysiology Division, Department of Pathophysiology and Endocrinology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland   +7 more
core   +1 more source

Treatment of ophthalmopathy in the course of Graves’ disease

Journal of Education, Health and Sport, 2019
: Introduction: Graves’ disease is an autoimmune disease in which the TSH receptor (TSHR) is an autoantigen. Its stimulation by antibodies inhibiting thyrotropin binding causes increased secretion of free thyroid hormones and consequently symptoms of ...
Magdalena Woźniak, Ewa Tywanek, Grzegorz Rudzki, Joanna Świrska, Agnieszka Zwolak, Robert Jan Łuczyk   +5 more
doaj   +3 more sources